AlphaYouRA
Insider selling
Raymond Anderson sold $351K of Monopar Therapeutics (MNPR) stock
Raymond Anderson, Dir of Monopar Therapeutics (MNPR), sold 3,142 shares of MNPR stock worth $351K, per an SEC Form 4 filed Aug 27, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 25, 2026, 2 days before it was made public.
MNPR has moved -13.6% since the trade date, from $110.82 to $95.72 (Sep 21, 2026 close).
- Traded
- Aug 25, 2026
- Disclosed
- Aug 27, 2026
- Filing delay
- 2 days
- Price since
- -13.6%
- Role
- Dir
- Source
- SEC Form 4
More MNPR insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.